Literature DB >> 31615921

Diffuse Cystic Lung Diseases.

Baha Obaidat1, Dina Yazdani1, Kathryn A Wikenheiser-Brokamp2, Nishant Gupta3.   

Abstract

Diffuse cystic lung diseases (DCLDs) are a group of diverse pulmonary disorders with varying pathophysiology that are characterized by the presence of thin-walled, air-filled spaces within lung parenchyma. High-resolution computed tomography plays a crucial role in the evaluation of DCLDs, and cyst characteristics such as morphology, distribution, and the presence of other associated radiologic findings can help distinguish between different DCLDs. DCLDs can be classified according to their underlying pathophysiology as neoplastic, genetic, lymphoproliferative, infectious, associated with other forms of interstitial lung disease, or related to smoking. In this review we will provide a clinical overview on the most common DCLDs that are encountered in clinical practice: lymphangioleiomyomatosis, pulmonary Langerhans cell histiocytosis, Birt-Hogg-Dubé syndrome, and lymphoid interstitial pneumonia/follicular bronchiolitis, with a focus on practical aspects that can help clinicians in the optimal diagnosis and management of patients with DCLDs.
Copyright © 2020 by Daedalus Enterprises.

Entities:  

Keywords:  Birt-Hogg-Dubé syndrome; follicular bronchiolitis; lymphangioleiomyomatosis; lymphoid interstitial pneumonia; pulmonary Langerhans cell histiocytosis

Year:  2019        PMID: 31615921     DOI: 10.4187/respcare.07117

Source DB:  PubMed          Journal:  Respir Care        ISSN: 0020-1324            Impact factor:   2.258


  3 in total

1.  Two most common diagnoses among myriads of cystic lung diseases.

Authors:  J Swol; D Würflein; J Böhm; J H Ficker
Journal:  Hippokratia       Date:  2021 Apr-Jun       Impact factor: 0.522

Review 2.  Paediatric pulmonary Langerhans cell histiocytosis.

Authors:  Mhairi Barclay; Rebecca Devaney; Jayesh M Bhatt
Journal:  Breathe (Sheff)       Date:  2020-06

3.  Pulmonary Artery Enlargement: An Independent Risk Factor for Mortality in Patients Hospitalized With COVID-19.

Authors:  Moussa A Riachy; Anis Ismail; Mohamad Awali; Fadi Farah; Sara F Haddad; Anthony Kerbage; Noel Aoun; Ghassan Sleilaty
Journal:  Mayo Clin Proc Innov Qual Outcomes       Date:  2022-07-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.